Tea Polysaccharide (TPS) Reduces Astrocytes Apoptosis Induced by Oxygen-Glucose Deprivation/Reoxygenation by Regulating the miR-375/SRXN1 Axis by Ying Jiang, Hongmei Sun, Zhiqi Yin, Jun Yan

Get full text

Single-cell RNA sequencing reveals potential therapeutic targets in the tumor microenvironment of lung squamous cell carcinoma by Junda Fan, Yu Chen, Yue Gong, Hongmei Sun, Rui Hou, Xiaoya Dou, Yanping Zhang, Cheng Huo

Get full text

Transcriptome profiling reveals key genes in eggplant (Solanum melongena) roots under salt stress by Hongmei Sun, Yong Wang, Lianbin Cao, Yihan Wang, Zhaoyang Wei, Li Song, Jun Jiang, Junhe Liu, Shilin Tian

Get full text

Therapeutic Potential of Bee and Wasp Venom in Anti-Arthritic Treatment: A Review by Hongmei Sun, Yunxia Qu, Xiaojing Lei, Qingzhu Xu, Siming Li, Zhengmei Shi, Huai Xiao, Chenggui Zhang, Zhibin Yang

Get full text

Multi-target neuroprotection by dl-PHPB in APP/PS1 mice: a proteomic analysis by Yingni Sun, Yingni Sun, Yingni Sun, Guoliang Bai, Kangmin Yang, Yong Feng, Hongmei Sun, Li Xian, Hongwei Gao

Get full text

An effective approach to cartilage regeneration using antler stem cell-conditioned medium by Jue Zhou, Baorui Xing, Qianqian Guo, Jianwei Zhao, Xunsheng Li, Datao Wang, Zhigang Yue, Jinpeng Lv, Yidi Jiang, Hongmei Sun

Get full text

Metagenomic and physicochemical profiling reveal microbial functions in pit mud for Jiang-Nong Jianxiang Baijiu fermentation by Lianbin Cao, Hongmei Sun, Ziyi Xu, Xiaoxiao Xu, Guangchuan Shi, Jianqiang Zhang, Changli Liang, Tongbiao Li, Chaoying Liu, Mingcheng Wang, Shilin Tian, Enzhong Li

Get full text

Efficacy and safety of KN026 and docetaxel for HER2‐positive breast cancer: a phase II clinical trial by Jianli Ma, Jingxuan Wang, Ting Xu, Quchang Ouyang, Xiaojia Wang, Jingfen Wang, Lu Gan, Zhong Ouyang, Daren Lin, Tao Sun, Changping Shan, Herui Yao, Baochun Zhang, Zhengguang Li, Zhixiang Zhuang, Ying Lu, Hongwei Yang, Jian Huang, Xingwang Yang, Hongmei Sun, Qingyuan Zhang

Get full text

Global, regional and national burden of rheumatoid arthritis from 1990 to 2021, with projections of incidence to 2050: a systematic and comprehensive analysis of the Global Burden... by Yingnan Ma, Haiyan Chen, Wenhua Lv, Siyu Wei, Yuping Zou, Ruilin Li, Jiacheng Wang, Wei She, Linna Yuan, Junxian Tao, Xuying Guo, Shuo Bi, Hongsheng Tian, Ye Ma, Hongmei Sun, Chen Sun, Jing Xu, Yu Dong, Jingxuan Kang, Hongchao Lv, Mingming Zhang, Yongshuai Jiang

Get full text

Plasma proteomics-based risk scores for psoriasis prediction: a novel approach to early diagnosis by Siyu Wei, Zehong Yue, Chen Sun, Yuping Zou, Haiyan Chen, Junxian Tao, Jing Xu, Yuan Xu, Ning Wang, Yan Guo, Qinduo Ren, Chang Wang, Songlin Lu, Ye Ma, Yu Dong, Chen Zhang, Hongmei Sun, Guoping Tang, Fanwu Kong, Wenhua Lv, Zhenwei Shang, Mingming Zhang, Yongshuai Jiang, Hongchao Lyu

Get full text

A multicenter, randomized, double-blind trial comparing LY01011, a biosimilar, with denosumab (Xgeva®) in patients with bone metastasis from solid tumors by Mingchuan Zhao, Xichun Hu, Pengpeng Zhuang, Aiping Zeng, Yan Yu, Zhendong Chen, Hongmei Sun, Weihua Yang, Lili Sheng, Peijian Peng, Jingfen Wang, Tienan Yi, Minghong Bi, Huaqiu Shi, Mingli Ni, Xiumei Dai, Changlu Hu, Hongjie Xu, Dongqing Lv, Qingshan Li, Kaijian Lei, Xia Yuan, Ou Jiang, Xicheng Wang, Baihui Hu, Zhe Hou, Zhaoping Su, Song Zheng, Ming Zhou, Changlin Dou

Get full text

First‐line serplulimab plus chemotherapy in extensive‐stage small‐cell lung cancer: Updated results and biomarker analysis from the ASTRUM‐005 randomized clinical trial by Ying Cheng, Shuang Zhang, Liang Han, Lin Wu, Jun Chen, Peiyan Zhao, Hongmei Sun, Guilan Wen, Yinghua Ji, Anastasia Zimina, Jianhua Shi, Zhijie Pan, Jinsheng Shi, Xicheng Wang, Yuansong Bai, Tamar Melkadze, Yueyin Pan, Xuhong Min, Maksym Viguro, Xingya Li, Yanqiu Zhao, Junquan Yang, Tamta Makharadze, Ekaterine Arkania, Haoyu Yu, Jing Li, Fang Yang, Xinyi Yang, Chen Ling, Qingyu Wang, Yongqiang Shan, Jun Zhu, the ASTRUM‐005 Study Group

Get full text

Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial by Chuanhua Zhao, Yanqiao Zhang, Gang Wang, Jinfang Zheng, Weiqing Chen, Zheng Lu, Li Zhuang, Shanzhi Gu, Lei Han, Zhendong Zheng, Zujiang Yu, Yongsheng Yang, Hongmei Sun, Xiaoyong Wei, Ying Cheng, Hailan Lin, Bo Zhu, Guicheng Wu, Kaijian Lei, Wei Wang, Yuwen Wang, Kehe Chen, Ximing Xu, Cuiping Zheng, Yanzhi Bi, Sijuan Ding, Jingdong Zhang, Wei Li, Hailong Liu, Jun Wang, Xianling Liu, Yangfeng Du, Lianming Cai, Jingran Wang, Zhanxiong Luo, Baocai Xing, Jie Shen, Lin Yang, Jianbing Wu, Ou Jiang, Zhigang Peng, Xiuli Liu, Bangwei Cao, Liangfang Shen, Aibing Xu, Aimin Li, Shaojun Chen, Ting Fu, Jian Chen, Chuan Jin, Lei Zhang, Jun Lv, Chengwu Zhang, Xiaoman Zhang, Yu Wang, Huo Su, Qiang Zhou, Wenlin Gai, Liangzhi Xie, Jianming Xu

Get full text